Myocardial and lung injury after cardiopulmonary bypass: Role of interleukin (IL)-10

Annals of Thoracic Surgery

Volumn 76, Issue 1, 2003, Pages 117-123

  Giomarelli, Pierpaolo ^a   Scolletta, Sabino ^a   Borrelli, Emma ^a   Biagioli, Bonizella ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CAREGIVER; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART MUSCLE INJURY; HEART PROTECTION; HEMODYNAMICS; HUMAN; LUNG INJURY; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROTECTION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; STANDARDIZATION;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; STEROIDS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038676410     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)00194-2     Document Type: Article

References (25)

1. Kirklin JK. The postperfusion syndrome: inflammation and the damaging effects of cardiopulmonary bypass. In: Tinker JH, ed. Cardiopulmonary bypass: current concept and controversies. Philadelphia: WB Saunders, 1989:131-146.
2. Edmunds LH. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998;66(Suppl):S12-6.
3. Wan S, LeClerc JC, Vincent JL. Cytokine responses to cardiopulmonary bypass. Lessons learned from cardiac transplantation. Ann Thorac Surg 1997;63:269-76.
4. Lee JIK, Burckart GJ. Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol 1998;38:981-93.
5. Kollias G, Douni E, Kassiotis G, Kontoyiannis D. The function of tumor necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Ann Rheum Dis 1999;58(Suppl 1):132-9.
6. Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: antiinflammatory and immunosuppressive mediators. Immunol Today 1997;18:428-32.
7. Patrick DA, Moore FA, Moore EE, Barnet CC, Sillimann CC Jr. The inflammatory profile of inteleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in post-injury multiple organ failure. Am J Surg 1996;172:425-31.
8. Wan S, Izzat MB, Lee TW, et al. Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury. Ann Thorac Surg 1999;68:52-7.
9. Krakauer T. IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. Immunol Lett 1995;45:61-5.
10. Lane JS, Todd KE, Lewis MP, et al. Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischemia/reperfusion. Surgery 1997;122:288-94.
11. Yang Z, Zingarelli B, Szabo C. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 2000;101:1019-26.
12. Chaney MA. Corticosteroids and cardiopulmonary bypass: a review of clinical investigations. Chest 2002;121:921-31.
13. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. JAMA 1992;267:2344-8.
14. Tassani P. Corticosteroids during operations using cardiopulmonary bypass. J Clin Anesth 2000;12:242-7.
15. Buckberg GD. Antegrade/retrograde blood cardioplegia to ensure cardioplegic distribution: operative techniques and objectives. J Card Surg 1989;4:216-38.
16. Teoh KHT, Bradley CA, Gauldie J, Burrows H. Steroids inhibition of cytokine-mediated vasodilation after warm heart surgery. Circulation 1998;92(Suppl II):347-53.
17. Wan S, LeClaerc JL, Schmartz D, et al. Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients. Am Heart J 1997;133:335-9.
18. Chaney MA, Nikolov MP, Blakeman B, Bakhos M, Slogoff S. Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation. Anesth Analg 1998;87:27-33.
19. Asimakopoulos G, Smith PLC, Ratnatunga CP, Taylor KM. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg 1999;68:1107-15.
20. El Azab SR, Rosseel PMJ, De Lange JJ, et al. Dexamethasone decrease the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesth 2002;88:496-501.
21. Haring F, Cesnjevar R, Mahmoud FO, von der Emde J. Perioperative factors influencing interleukin-10 release under cardiopulmonary bypass. Thorac Cardiovasc Surg 1999;47:361-8.
22. Nathan N, Preux PM, Feiss P, Denizot Y. Plasma interleukin-4, interleukin-10, and interleukin-13 concentrations and complications after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2000;14:156-60.
23. Wei M, Kuukasjarvi P, Laurikka J, et al. Cytokine responses and myocardial injury in coronary artery bypass grafting. Scand J Clin Laboratory Invest 2001;61:161-6.
24. Richter JA, Meisner H, Tassani P, et al. Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting. Ann Thorac Surg 1999;69:77-83.
25. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002;21:232-44.